https://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyMon, 22 Jul 2024 10:57:13 +0200Fri, 12 Jul 2024 14:10:00 +0200https://www.ema.europa.eu/en/medicines/human/EPAR/emtricitabine-tenofovir-disoproxil-krka-ddHuman medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Krka d.d., emtricitabine,tenofovir disoproxil, Date of authorisation: 28/04/2017, Revision: 12, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/emtricitabine-tenofovir-disoproxil-krka-ddFri, 12 Jul 2024 14:10:00 +0200Human medicinehttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-4686-steps-after_en.pdfEmtricitabine/Tenofovir disoproxil Krka d.d. : EPAR - Procedural steps taken and scientific information after authorisation (archive)https://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-4686-steps-after_en.pdfTue, 02 Jul 2024 15:04:00 +0200Human medicine